Form 4: AtriCure COO Acquires Shares Through Employee Stock Purchase Plan
Insider Transaction Report
AtriCure, Inc.'s Chief Operating Officer, Douglas J. Seith, acquired 550 shares of common stock at $25.84 per share through the company's Employee Stock Purchase Plan, increasing his total beneficial ownership to 184,113 shares.
Summary
- Douglas J. Seith, Chief Operating Officer of AtriCure, Inc., acquired 550 shares of common stock.
- The acquisition occurred on June 30, 2025.
- Shares were purchased at a price of $25.84 per share.
- The purchase was made through the AtriCure, Inc. 2018 Employee Stock Purchase Plan (ESPP) for the period ended June 30, 2025.
- The purchase price of $25.84 represents 85% of the closing price of AtriCure's common stock on January 2, 2025, which was $30.40.
- Following this transaction, Douglas J. Seith beneficially owns 184,113 shares of AtriCure common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase.
Sentiment
Score: 6
Explanation: The sentiment is mildly positive as it indicates an insider increasing their stake in the company, albeit through a routine employee stock purchase plan. It suggests continued confidence from management.
Positives
- Chief Operating Officer Douglas J. Seith increased his direct ownership in AtriCure, Inc. by acquiring 550 shares, which can signal management confidence.
- The acquisition was made through the company's Employee Stock Purchase Plan (ESPP), indicating participation in employee benefit programs and alignment of interests.
- The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned, systematic approach to share acquisition rather than a discretionary open market purchase.
Future Outlook
NA
Industry Context
This Form 4 filing details a routine insider transaction under an Employee Stock Purchase Plan, which is a common benefit offered by publicly traded companies across various industries to encourage employee ownership and alignment with shareholder interests. It does not provide specific insights into broader industry trends or competitive dynamics beyond the company's internal compensation practices.
Related Party Transactions
- Acquisition of shares by Chief Operating Officer Douglas J. Seith from AtriCure, Inc. through the company's Employee Stock Purchase Plan.
Stakeholder Impact
- Shareholders: Increased insider ownership may be viewed positively as it aligns management's interests with those of shareholders.
- Employees: The transaction highlights the availability and utilization of the Employee Stock Purchase Plan, which is a benefit for eligible employees.
Key Dates
| Date | Description |
|---|---|
| 2025-01-02 | First trading day of the applicable offering period for the ESPP, with a closing price of $30.40 used for the purchase price calculation. |
| 2025-06-30 | Date of acquisition of 550 shares of common stock by Douglas J. Seith pursuant to the ESPP. |
| 2025-07-02 | Date the Form 4 was filed with the SEC. |
Keywords
AtriCure, ATRC, Douglas J. Seith, Form 4, SEC filing, insider transaction, stock acquisition, employee stock purchase plan, ESPP, common stock, corporate officer, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.